Jeff Bezos' Next Trillion Dollar Bet (shocking)
Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet...but in the next 6 months that's all they'll talk about.
Financials
| Curr Year EPS Estimate | -6.34 |
| Next Quarter EPS Estimate | -1.69 |
| Profit Margin | -1.74 |
| Return on Assets | -0.18 |
| Return on Equity | -0.70 |
| Revenue | 492,852,992 |
| Earnings Per Share | -7.46 |
| Revenue Per Share | 4.29 |
| Gross Profit | 414,801,000 |
| Quarterly Revenue Growth | 1.28 |
General
| Name | Alnylam Pharmaceuticals, Inc |
| Ticker | ALNY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 1,453 |
About Alnylam Pharmaceuticals, Inc
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; lumasiran for the treatment of advanced PH1 and recurrent renal stones; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; and vutrisiran for the treatment of ATTR amyloidosis. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG to develop, manufacture, and commercialize RNAi therapeutics for the treatment of proprotein convertase subtilisin/kexin type 9, hypercholesterolemia, and other human diseases; with Vir Biotechnology, Inc. to develop and commercialize RNAi therapeutics to treat SARS-CoV-2, the virus that causes the disease COVID-19; Dicerna Pharmaceuticals, Inc. to develop and commercialize investigational RNAi therapeutics for the treatment of alpha-1 antitrypsin deficiency-associated liver disease; and with Ionis Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Earnings
A tornado hit an Oklahoma newsroom built in the 1920s. The damage isn't stopping the presses
SULPHUR, Okla. (AP) — When Oklahoma and national officials held a press conference Monday to discuss the scale of devastation , Kathy John did what she always does: She showed up to report on it for the town’s weekly newspaper, the Sulphur Times-Democrat.
Colombia breaks diplomatic ties with Israel but its military relies on key Israeli-built equipment
BOGOTA, Colombia (AP) — Colombia has become the latest Latin American country to announce that it over its military campaign in Gaza, but the repercussions for the South American nation could be broader than for other countries because of longstanding bilateral agreements over security matters.
The No. 1 Crypto for 2024 - Ad
We're entering the final crypto bull run, and 2024 will be your last chance to ever get rich from crypto. These five tiny cryptos are believed to create generational wealth over the next 12 months. $30 trillion is poised to funnel into the crypto markets thanks to a new government regulation just signed.
Biden Vs. Trump Contest Could Be Lost Cause For One Candidate If History Were Anything To Go By, According To Pollster
The 2024 election is viewed as closely contested at this stage, with no clear lead emerging, but historical trends suggest a likely winner.
Maui sues cell carriers over wildfire warning alerts that were never received during service outages
HONOLULU (AP) — Had emergency responders known about widespread cellphone outages during the height of last summer's deadly , they would have used other methods to warn about the disaster, county officials said in a lawsuit.
Crypto Reboot Finally Makes An 8,788% Return Possible [NOT Bitcoin] - Ad
A crypto millionaire is revealing that a different cryptocurrency is going to do even better... It's not simply "buy the dip." Instead, it's a strategy that James learned during the dot com stock market crash. Not only has this strategy worked in a crash... it needs a crash to work best.
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
PARIS (AP) — U.S. track and field athletes have around four dozen pieces to choose from when assembling their uniforms at the Olympics. The one grabbing the most attention is a high-cut leotard that barely covers the bikini line and has triggered debate between those who think it is sexist and others who argue they don't need the internet to make sure they have good uniforms.
South Korea's 5-Year Plan To Grow Its Console Gaming Market By 2028
South Korea's plan to boost console gaming, diversifying from mobile platforms, through strategic partnerships and market growth projections
The A.I. Story Nobody is Telling You (Read ASAP) - Ad
There's been a lot of buzz surrounding A.I. over the past couple of years -- but there's only ONE story you should be worried about. Whether you have $500 or $500,000, this radical new A.I. Innovation will have a direct impact on your wealth.
Trump vs. Biden: Nationwide Poll Shows Key Issue Decidedly Tilts Equation In Favor Of One Candidate
Even though the economy has been relatively stable despite challenges, voters remain unconvinced about the Biden administration's performance.
Jim Cramer Explains What Could Trigger Further Market Decline: 'If You Want To Get Out, Go Ahead ...'
CNBC host Jim Cramer has outlined potential factors that could lead to further market decline, advising investors to be cautious about their buying and selling decisions.
Elon's New A.I. Device is About to Shock the World - Ad
Using this device you see... Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in... "The next step in human evolution."
Bill Gates Shares Heartwarming Scuba Diving Photo With Daughter On Her 28th Birthday: 'I'm In Awe Of How You Dive Headfirst Into Everything.'
Bill Gates and Melinda French Gates each shared heartfelt social media posts to celebrate their daughter Jennifer's 28th birthday, highlighting her achievements as a mother, medical student, and equestrian.
This Man, Who Never Went To University, Is Making $1.2M-A-Year At Deloitte At The Age Of 30
Ben Newton, a former apprentice at Deloitte, has achieved the feat of becoming a partner at the age of 30, earning $1.2 million a year.
Buy Alert: Invest in This Coin Before... [Details Inside] - Ad
Today, Ian issued a new "buy alert. He's calling this one "the greatest investment in history," and adds: "All my data is clear. It will be 20X bigger than bitcoin. "But you'll want to invest before the upgrade date.
Elizabeth Warren Says Trump Had Only 2 Accomplishments As President: 'Huge Difference Between' Biden, Trump
Elizabeth Warren thinks Donald Trump only accomplished two things when he was president and neither is highlighted as a positive by the senator.
Missouri's $2B Marijuana Market Hits Record Sales In March, Eyes Future Growth With Microbusiness Licenses
The Missouri cannabis market set a new monthly sales record in March, reaching nearly $125 million. According to the latest data from the Missouri Department of Health and Senior Services (DHSS), the adult-use cannabis sector contributed $108.7 million in March, with medical cannabis adding another $16 million, culminating in a total of $124.7 million.
Nvidia CEO Says It Will Spark "the Next Revolution" Beyond AI - Ad
Declares this radical biotechnology "is going to be flat out one of the biggest [tech revolutions] ever." And this $10 stock is at the center of all.
An NPR editor who wrote a critical essay on the company has resigned after being suspended
NEW YORK (AP) — A National Public Radio editor who wrote an essay criticizing his employer for promoting liberal views resigned on Wednesday, a day after it was revealed that .
Nvidia Robotics Expert Praises Tesla FSD's 'Human-Like Maneuvers' As Magical
Tesla's latest FSD feature has impressed users like Nvidia employee Yuke Zhu who called it 'magical'. Tesla has made FSD more accessible with price cuts and free trials.
Why James Altucher SOLD All His Bitcoin - Ad
Crypto genius James Altucher has been praising Bitcoin since it was trading for $61. But now he's buying another coin like crazy... and it's not Bitcoin!
First major attempts to regulate AI face headwinds from all sides
DENVER (AP) — Artificial intelligence is helping decide which Americans get the job interview, the apartment, even medical care, but the to reign in bias in AI decision making are facing headwinds from every direction.
US job openings fall to 8.5 million in March, the lowest level in more than 3 years
WASHINGTON (AP) — U.S. jobs openings slid in March to the lowest level in more than three years, but stayed at historically high levels in a sign that the job market remains resilient in the face of higher interest rates.
5 Wall Street Legends Just Bought This One Stock - Ad
"If you're not at the table, you're on the menu," says former Goldman Sachs VP, Dr. David Eifrig.
Traffic snarled as workers begin removing bridge over I-95 following truck fire in Connecticut
NORWALK, Conn. (AP) — Workers on Friday began removing a bridge over a Connecticut highway that was damaged in a fiery crash involving a gasoline tanker truck — a project expected to keep both sides of Interstate 95 closed through the weekend and extend a traffic nightmare on the major artery linking New England and New York.
General Motors And Ford Are Facing The Same Challenge As They Run Back To Gas-Powered Trucks
General Motors (NYSE: GM) and Ford Motor (NYSE: F) will report their first quarter results next week.
The Next Nvidia? - Ad
Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet...but in the next 6 months that's all they'll talk about.
Alibaba Rival Temu Joins Tech Giants List Under EU Scrutiny, Crosses User Threshold for Enhanced Regulation
Temu, rival of Alibaba Group, will face strict EU regulations for online content as its monthly users in Europe surpass 45 million threshold.
More cows are being tested and tracked for bird flu. Here's what that means
U.S. health and agriculture officials are and tracking of bird flu in dairy cows in an urgent effort to understand — and stop — the growing outbreak.
One Crypto Can Change Your Financial Life - Ad
The catch is you won't be able to become a millionaire by buying Bitcoin today. There are five little-known coins I've discovered that I believe will skyrocket over the course of the next few months.
Why Media Company Omnicom Shares Are Trading Higher Premarket Today
Omnicom Group reported 5.4% revenue growth, with organic growth of 4.0%. Adjusted EPS beat expectations.
Elon Musk's FSD Is The End Of Manual Driving? Tesla Bull Gene Munster Believes 'Somebody Born Today Is Probably Never Going To Drive A Car'
Tesla has decided to reduce the price of its 'full self-driving' subscription by half to $99 per month. This decision has led Gene Munster, Managing Partner at Deepwater Asset Management, to predict the end of manual driving.
Market Warning: Don't Buy This... - Ad
Today's "bizzarro" market has one 50-year Wall Street veteran concerned. He believes most investors are about to make this huge mistake.
TotalEnergies Trades Mature Assets for Growth In Low-Emission Congolese Oil Field
TotalEnergies SE has signed a deal with Trident Energy for purchase and sale transactions in Congo, increasing its stake in the Moho license and selling its interests in the Nkossa and Nsoko II licenses.
As Israel Weighs Next Move After Iran's Unprecedented Attack, Western Allies Urge Restraint
Following a significant and unprecedented assault from Iran, Israel's leadership is deliberating an appropriate countermeasure.
"Retirement Secret" Showed 995% Gain Last Time We Shared It - Ad
It's a straightforward way to come out on top no matter who wins this November... It's not cryptos, or options, and anyone can do it.
Tesla Bull Says 'Don't Know...What's Going To Happen To TSLA Stock Next Week' Ahead Of Earnings Call: 'Much Depends On...'
Black expects the $25K compact's production to commence in 2026, despite the prioritization of the robotaxi project.
Tens of thousands of Colombians protest against the leftist president's reform agenda
BOGOTA, Colombia (AP) — Thousands of Colombians took to the streets Sunday in the latest rebuke of leftist President Gustavo Petro's reform agenda.
READ THIS If You Missed Out on the AI Boom - Ad
Radical new biotechnology predicted to grow 320,000% in 3 years. Nvidia's CEO calls it "the next amazing revolution." And one small company poised to dominate this revolution trades for just $10.
Donald Trump Argues 'Political Prosecution' Before Jury Selection In New York Trial: 'Judge Not Going To Allow Me To Escape This Scam'
Recapping the wild first day of the criminal trial against former President Donald Trump. Key highlights and why some jurors were dismissed.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.